Common arthritis drug could help fight Parkinson's

NCT ID NCT07246278

Recruiting now Disease control Sponsor: Tanta University Source: ClinicalTrials.gov ↗

Summary

This study is testing whether celecoxib, a medication typically used for arthritis pain, can help control Parkinson's disease symptoms. Researchers believe brain inflammation plays a key role in Parkinson's progression and want to see if reducing this inflammation helps patients. The trial will involve 80 adults with Parkinson's who will take the drug while researchers track their symptoms and safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Tanta Unuversity
RECRUITING

Tanta, 31527, Egypt

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PARKINSON DISEASE